xml version 1.0 encoding utf-8 standalone no
mets ID sort-mets_mets OBJID sword-mets LABEL DSpace SWORD Item PROFILE METS SIP Profile xmlns http:www.loc.govMETS
xmlns:xlink http:www.w3.org1999xlink xmlns:xsi http:www.w3.org2001XMLSchema-instance
metsHdr CREATEDATE 2012-08-03T20:01:32
agent ROLE CUSTODIAN TYPE ORGANIZATION
name BioMed Central
dmdSec sword-mets-dmd-1 GROUPID sword-mets-dmd-1_group-1
mdWrap SWAP Metadata MDTYPE OTHER OTHERMDTYPE EPDCX MIMETYPE textxml
epdcx:descriptionSet xmlns:epdcx http:purl.orgeprintepdcx2006-11-16 xmlns:MIOJAVI
epdcx:description epdcx:resourceId sword-mets-epdcx-1
epdcx:statement epdcx:propertyURI http:purl.orgdcelements1.1type epdcx:valueURI http:purl.orgeprintentityTypeScholarlyWork
epdcx:valueString Molecular diagnostic testing for Klinefelter syndrome and other male sex chromosome aneuploidies
AbstractBackgroundMale sex chromosome aneuploidies are underdiagnosed despite concomitant physical and behavioral manifestations.ObjectiveTo develop a non-invasive, rapid and high-throughput molecular diagnostic assay for detection of male sex chromosome aneuploidies, including 47,XXY (Klinefelter), 47,XYY, 48,XXYY and 48,XXXY syndromes.MethodsThe assay utilizes three XYM and four XA markers to interrogate Y:X and X:autosome ratios, respectively. The seven markers were PCR amplified using genomic DNA isolated from a cohort of 323 males with aneuploid (n = 117) and 46,XY (n = 206) karyotypes. The resulting PCR products were subjected to Pyrosequencing, a quantitative DNA sequencing method.ResultsReceiver operator characteristic (ROC) curves were used to establish thresholds for the discrimination of aneuploid from normal samples. The XYM markers permitted the identification of 47,XXY, 48,XXXY and 47,XYY syndromes with 100% sensitivity and specificity in both purified DNA and buccal swab samples. The 48,XXYY karyotype was delineated by XA marker data from 46,XY; an X allele threshold of 43% also permitted detection of 48,XXYY with 100% sensitivity and specificity. Analysis of X chromosome-specific biallelic SNPs demonstrated that 43 of 45 individuals (96%) with 48,XXYY karyotype had two distinct X chromosomes, while 2 (4%) had a duplicate X, providing evidence that 48,XXYY may result from nondisjunction during early mitotic divisions of a 46,XY embryo.ConclusionsQuantitative Pyrosequencing, with high-throughput potential, can detect male sex chromosome aneuploidies with 100% sensitivity.
Gruen, Jeffrey R
Rivkees, Scott A
Tartaglia, Nicole R
Rinder, Henry M
http:purl.orgeprinttermsisExpressedAs epdcx:valueRef sword-mets-expr-1
http:purl.orgdcelements1.1language epdcx:vesURI http:purl.orgdctermsRFC3066
epdcx:sesURI http:purl.orgdctermsW3CDTF 2012-04-23
BioMed Central Ltd
Karl Hager et al.; licensee BioMed Central Ltd.
International Journal of Pediatric Endocrinology. 2012 Apr 23;2012(1):8
fileGrp sword-mets-fgrp-1 USE CONTENT
file sword-mets-fgid-0 sword-mets-file-1
FLocat LOCTYPE URL xlink:href 1687-9856-2012-8.xml
sword-mets-fgid-1 sword-mets-file-2 applicationpdf
structMap sword-mets-struct-1 structure LOGICAL
div sword-mets-div-1 DMDID Object
RESEARCHOpenAccessMoleculardiagnostictestingforKlinefelter syndromeandothermalesexchromosome aneuploidiesKarlHager1*,KoriJennings1,SeiyuHosono1,SusanHowell2,JeffreyRGruen3,4,5,6,ScottARivkees3,4,7, NicoleRTartaglia2andHenryMRinder8AbstractBackground: Malesexchromosomeaneuploidiesareunderdiagnoseddespiteconcomitantphysicalandbehavioral manifestations. Objective: Todevelopanon-invasive,rapidandhigh-throughputmoleculardiagnosticassayfordetectionofmale sexchromosomeaneuploidies,including47,XXY(Klinefelter),47,XYY,48,XXYYand48,XXXYsyndromes. Methods: TheassayutilizesthreeXYMandfourXAmarkerstointerrogateY:XandX:autosomeratios,respectively. ThesevenmarkerswerePCRamplifiedusinggenomicDNAisolatedfromacohortof323maleswithaneuploid (n=117)and46,XY(n=206)karyotypes.TheresultingPCRproductsweresubjectedtoPyrosequencing,a quantitativeDNAsequencingmethod. Results: Receiveroperatorcharacteristic(ROC)curveswereusedtoestablishthresholdsforthediscriminationof aneuploidfromnormalsamples.TheXYMmarkerspermittedtheidentificationof47,XXY,48,XXXYand47,XYY syndromeswith100%sensitivityandspecificityinbothpurifiedDNAandbuccalswabsamples.The48,XXYY karyotypewasdelineatedbyXAmarkerdatafrom46,XY;anXallelethresholdof43%alsopermitteddetectionof 48,XXYYwith100%sensitivityandspecificity.AnalysisofXchromosome-specificbiallelicSNPsdemonstratedthat43 of45individuals(96%)with48,XXYYkaryotypehadtwodistinctXchromosomes,while2(4%)hadaduplicateX, providingevidencethat48,XXYYmayresultfromnondisjunctionduringearlymitoticdivisionsofa46,XYembryo. Conclusions: QuantitativePyrosequencing,withhigh-throughputpotential,candetectmalesexchromosome aneuploidieswith100%sensitivity. Keywords: Pyrosequencing,Sexchromosomeaneuploidy,Klinefelter(47,XXY)syndrome,47,XYYsyndrome,48,XXYY syndrome,48,XXXYsyndrome,MaleinfertilityIntroductionKlinefeltersyndrome(KS,alsoknownas47,XXY)and 47,XYYsyndromearethetwomostcommonsex chromosomeaneuploidiesinhumanswithprevalenceof approximately1in600 1000males[1-4].Individuals withKSareusuallytalladolescentsandadultswhohave hypergonadotrophichypogonadismwithsmalltesticles. However,theKSphenotypeishighlyvariableandindividualsmaynotshowthesephysicalfeaturestoadegree thatdistinguishesthemfromthegeneralmalepopulation. Maleswith47,XYYarealsotallerthanaverage,butin contrasttoKS,theyusuallydonothavephenotypic characteristicstodifferentiatethemfrom46,XYmales. Comparedto46,XYmales,individualswithKSor47,XYY syndromeexhibitagreaterincidenceofbehavioral problems,psychiatricdisordersandneuropsychological characteristicsincludingdevelopmentaldelaysanddifficultiesincognitive,verbalandsocialskills.Yetindividualswithbothsyndromesoftenfailtobeascertained. Newbornscreeningstudiesestimatethatonly25%ofall individualswithKS,and10%ofallindividualswith47, XYYarediagnosedduringtheirlifetime[6,7]. *Correspondence: firstname.lastname@example.orgJSGenetics,Inc,2ChurchSt.South,B-05,NewHaven,CT06519,USA Fulllistofauthorinformationisavailableattheendofthearticle 2012Hageretal.;licenseeBioMedCentralLtd..ThisisanOpenAccessarticledistributedunderthetermsoftheCreative CommonsAttributionLicense(http://creativecommons.org/licenses/by/2.0),whichpermitsunrestricteduse,distribution,and reproductioninanymedium,providedtheoriginalworkisproperlycited.Hager etal.InternationalJournalofPediatricEndocrinology 2012, 2012 :8 http://www.ijpeonline.com/content/2012/1/8
Morecomplexmalesexchromosomeaneuploidies, suchas48,XXYYand48,XXXY,arelesscommonthan KSwithprevalencesrangingfrom1in18,000to1in 100,000orgreater.Whilesomephenotypiccharacteristicsof48,XXYYand48,XXXYsyndromesoverlapwith KS,theuniqueandsignificantdifferencesinphysical appearance,cognitivefunction,socialandadaptiveskills observedinaffectedindividualsdifferentiatethese aneuploidiesfromKS[8,9]. Thegoldstandardfordetectionofchromosomeaneuploidiesiskaryotypeanalysis,aninvasive,time-consuming andlabor-intensiveprocess.Yetdespitethewidespread availabilityofkaryotyping,mostmaleswithsexchromosomeaneuploidyareneverdiagnosedduringtheirlifetime [6,7].Thus,thedevelopmentofmoreconvenientmethods fordetectionofsexchromosomeaneuploidiesshould facilitateidentificationoftheseindividuals,allowingthem toreceiveearlyevaluationandtherapeuticinterventionas indicated.Toaddressthisneed,wedevelopedatwo-stage PyrosequencingbasedassaywhichmeasuresY:XandX: autosomechromosomeratios.Usingthisapproach,we demonstrated100%sensitivityintheidentificationof maleswithsexchromosomeaneuploidy.Materials&methodsDNAsamplesDe-identifiedkaryotype-confirmedDNAsamplesfrom individualswithmalesexchromosomeaneuploidies (n=117)wereobtainedfromChildren'sHospitalColorado andtheUCDavisMINDInstitute(Dr.FloraTassone). Additionalde-identifiedkaryotype-confirmedDNA samplesfromsubjectswith45,X(n=1),46,XX(n=4),47, XXX(n=11),and46,XY(n=206)wereprovidedbythe abovesources,plustheYaleCytogeneticsLab(Dr.Peining Li)andtheGeneticsDiagnosticLabofChildren sHospital Boston(Dr.Bai-LinWu).Beforeuse,theDNAsamples werediluted20-foldwithnuclease-freewater.The concentrationofdilutedDNAwasdeterminedbyreal timePCRusingthehumanspecificprobeWIAF699as described.Onlysampleswithaconcentrationof dilutedDNA 1ng/ lwereusedastemplatesforPCRof theXYMandXAmarkers(seebelow).DNAisolationfrombuccalswabsBuccalswabswereobtainedfrompatientsofChildren s HospitalColoradoafterinfor medconsent.DNAwasisolated frombuccalcellsusingtheQiagenEZ1robotandEZ1DNA tissuekitaccordingtothemanufacturer sprotocol.Extracted DNAwasquantifiedbyrealtimePCRasabove.AssaydesignPyrosequencing(PSQ)assaysweredesignedtointerrogatetwotypesofmarkers.Thefirstclassofmarkers, designatedXYM,consistedofregionsoftheXandY chromosomeswithnearlyidenticalsequencethatdiffer byachromosome-specificbiallelicsinglenucleotide polymorphism,suchthatonealleleispresentonlyon theXchromosomeandtheotheralleleislocatedontheY chromosome.Candidatesequenceswereidentifiedby examiningcloselyrelatedgenespresentonbothXandY chromosomesoutsideoftheterminalpseudoautosomal regions(seeTable1ofreferenceandTable2ofreference).BLASTsearchesofthehumanreference genomesequencewereusedtoconfirmasinglematchto Table1StatisticalvaluescalculatedfromthepercentYallelesignalsofthethreeXYMmarkersforsamplesgrouped togetherbykaryotypeKaryotype47,XXY(n=42)47,XYY(n=26)48,XXXY(n=4)48,XXYY(n=45)46,XY(n=206) MarkerXYM1XYM2XYM3XYM1XYM2XYM3XYM1XYM2XYM3XYM1XYM2XYM3XYM1XYM2XYM3 Average 32.333.333.763.762.564.624.426.726.047.448.149.348.249.749.3 Median 32.333.433.763.662.264.724.126.725.747.648.049.448.249.849.2 StdDev 1.532.561.391.551.530.831.540.570.901.172.701.151.461.611.55 Maximum 38.940.639.067.865.966.826.427.327.350.658.351.851.953.253.3 Minimum 30.127.931.061.557.862.323.025.925.345.422.214.171.124.142.8 Table2StatisticalvaluescalculatedfromthepercentXallelesignalsofthefourXAmarkersforsamplesgrouped togetherbykaryotypeKaryotype48,XXYY(n=45)46,XY(n=206) MarkerXA1XA2XA3XA4XA1XA2XA3XA4 Average 56.854.148.550.442.335.333.032.0 Median 56.454.048.950.8126.96.36.1991.7 StdDev 1.742.572.433.472.512.032.993.56 Maximum 59.7188.8.131.520.242.637.251.3 Minimum 52.249.535.343.835.527.40.020.8 Hager etal.InternationalJournalofPediatricEndocrinology 2012, 2012 :8Page2of10 http://www.ijpeonline.com/content/2012/1/8
theXandYchromosomesforallsequencesenteredinto thePSQassaydesignsoftware(version1.0.6). Thesecondclassofmarkers,designatedXA,represent regionsoftheXchromosomethatarenearlyidenticalwith anautosomeexceptforasinglechromosome-specific base.Candidatesequencesforassaydesignwereidentified byBLASTsearchingthehumangenomereference sequencewiththesetofallX-chromosometranscripts obtainedfromtheENSEMBLdatabase.Highscoring matcheswhereatleast200baseswere > 95%identical A 46,XX B 46,XY C 47,XXY D 47,XYY Figure1 PyrogramsforDNAfroma46,XXfemale(A),a46,XYmale(B),a47,XXYKSmale(C),anda47,XYYmale(D)usingtheXYM3 assay. TheboxenclosesthetwonucleotidedispensationswhichdefinetheC/TSNP;theC-alleleisderivedfromtheX-chromosomeandtheT-allele isfromtheY-chromosome.Thepercentofeachalleleisshownintheshadedboxaboveeachpyrogram.They-axisdepictstheintensityoflightsignal inarbitraryunitsandthex-axisshowsthetimeofadditionofPyrosequnecingenzymes(E),substrates(S),andeachindividualnucleotidedispensat ion (A,C,G,orT). Hager etal.InternationalJournalofPediatricEndocrinology 2012, 2012 :8Page3of10 http://www.ijpeonline.com/content/2012/1/8
withonelocusontheX-chromosomeandoneonan autosomewereusedtogenerateconsensussequencesfor assaydesignbythePSQsoftware. PCRandextensionprimersforhighscoringassays weresynthesizedusingstandardmethodsbytheW. M.KeckFoundationBiotechnologyResourceLabof YaleUniversity.OneofthePCRprimersforeach assaywaslabeledatthe5endwithbiotin.Forall assays,theextensionprimerhadthesameorientationas theforwardPCRprimerandiscomplementarytothebiotinylatedtemplatestrandgeneratedwiththereversePCR primer.PCRandpyrosequencingAminimumof2.5nggenomicDNAwasusedastemplate ina25 lPCRreaction.EachPCRreactioncontained1X Hotstarbuffer(Qiagen),2.5mMMgCl2,200 Meach dNTP,1 MeachPCRprimer,0.5UHotstarTaqPlus (Qiagen).Reactionswereperformedasfollows:initial incubationof5minat95C;followedby45cyclesof30sec at95C,45secat56C,and60secat72C;then5minat 72Candafinalholdat4C.UponcompletionofPCR,the biotinylatedtemplatestrandwaspurifiedusingStreptavidin-SepharoseandtheFilterPreptool(Qiagen)according tothemanufacturer sinstructions.Theresultingsingle strandedtemplatewasannealedtotheappropriateextensionprimerandPyrosequencingwasperformedusing PyromarkQ96reagentsandPSQ96MAinstrument (Qiagen).Theallelepercentagewascalculatedbythe PSQsoftware(version2.1)andexportedforanalysis byMicrosoftExcel.ResultsPrincipleofassayTheassaymeasuresbothY:XandX:A(X:Autosome) chromosomeratiosbyPyrosequencing,aquantitative short-readDNAsequencingtechnology.Forthe firststep,threeXYMlociarePCRamplifiedwith specificprimerpairsandtheresultingamplicons subjectedtoPyrosequencing,yieldingthepercentof Y-chromosome-specificall elesignalforeachlocusand hence,theratiooftheYandXchromosomes.Figure1 showsPyrosequencingdatausingtheXYM3marker withDNAfroma46,XXfemale(A),46,XYmale(B),a 47,XXYindividual(C),anda47,XYYsubject(D).The percentYallelesignalhascloseagreementwiththe valuepredictedforeachkaryotype.Thelocationsofthe threeXYMmarkersontheXandYchromosomesare showninFigure2. Inthesecondstepoftheassay,Pyrosequencingofthe fourXAmarkersdeterminestheX:autosome(X:A)ratio, whichpermitsdifferentiationbetweenindividualswith 46,XYand48,XXYYkaryotypes.OverallperformanceofXYMmarkersToevaluatetheabilityofthethreeXYMmarkersto detectsexchromosomeaneuploidies,PCRandPyrosequencingwereperformedon339DNAsamplesfrom females(n=16)andmales(n=323),withthetechnician blindedtoeachindividual skaryotype.FollowingcompletionofPyrosequencing,thekaryotypeofeachsample wasmatchedtothedataforallthreemarkers.All samplesfromphenotypicfemales,includingindividuals witha46,XXkaryotype(n=4)andthosewithsexchromosomeaneuploidies(45,X,n=1and47,XXX,n=11),did notdisplaydetectableYalleleforanyofthethreeXYM markers(maximumYallelesignalof1.9%). DatageneratedwiththethreeXYMmarkerswere analyzedforthe323DNAsamplesfrommaleswith karyotype-confirmedsexchromosomeaneuploidies (n=117)or46,XY(n=206).Scatterplotsofthepercent YallelesignalforboththeXYM2andXYM3markers versusthepercentYallelesignaloftheXYM1marker areshowninFigure3.ForallthreeXYMmarkers,the dataforindividualswiththe48,XXXY,47,XXY,and47, XYYkaryotypesweretightlyclusteredanddistinguishablefrommaleswitha46,XYkaryotype.Asexpected fromtheknownY:Xchromosomeratio,thepercentY allelesignalsforthesubjectswith48,XXYYkaryotype overlappedwiththoseforthe46,XYmales.Thepercent Figure2 LocationsoftheXYMmarkersontheXandY chromosomes. XandYchromosomeideogramsaredrawntoscale usingdatafromtheUCSCgenomebrowser.Xchromosomeis 154.9MbandYchromosomeis57.8Mb. Hager etal.InternationalJournalofPediatricEndocrinology 2012, 2012 :8Page4of10 http://www.ijpeonline.com/content/2012/1/8
YallelesignalforbothXYM2andXYM3wasstrongly correlatedwithXYM1,withcorrelationcoefficients(r2) of0.90and0.94,respectively.Table1summarizesthe statisticaldatacalculatedforthemeasuredpercentY allelesignalofeachmarkerforsamplesgrouped accordingtokaryotype;theaveragepercentYallele signalforeachgroupwasclosetothepredictedvalue basedontheknownkaryotype.Detectionof47,XXY(KS),48,XXXYand47,XYYsyndromesToidentify47,XXY,48,XXXY,or47,XYYkaryotypes, receiveroperatorcharacteristic(ROC)curveswere constructedbyvaryingthepercentYallelesignallower andupperthresholdsforsamplesscoredasnormal46,XY karyotype(Figure4).Forthisanalysis,theaveragepercent YallelesignalforthethreeXYMmarkerswascalculated; thelowerthresholdwasincreasedfrom34%to48%by1% incrementswhilesensitivityandfalsepositiveratesfor detecting47,XXY(KS)and48,XXXYkaryotypeswere calculated.Allsampleswitheither47,XXYor48,XXXY karyotypesandaveragepercentYallelesignalslessthan thelowerthresholdvaluewereclassifiedastruepositives. Falsenegativesampleshadthesamekaryotypesandthe averagepercentYallelesignalabovethethreshold.True 0.0 10.0 20.0 30.0 40.0 50.0 60.0 70.0 0.010.020.030.040.050.060.070.0 % Y A l l e l e X Y M 1 46, XY 47, XXY 47, XYY 48, XXXY 48, XXYY 0.0 10.0 20.0 30.0 40.0 50.0 60.0 70.0 0.010.020.030.040.050.060.070.0 % Y A l l e l e X Y M 1 46, XY 47, XXY 47, XYY 48, XXXY 48, XXYYA B Figure3 PercentYallelesignalofXYM2(A)andXYM3(B)plottedagainstthepercentYallelesignalofXYM1for323DNAsamples frommalesubjectsgroupedbykaryotype. Foreachmarker,thepercentYallelesignalistheratioofsignalfromtheY-chromosomespecific alleledividedbythetotalsignalfromboththeY-andX-chromosomespecificalleles,expressedasapercentage. Hager etal.InternationalJournalofPediatricEndocrinology 2012, 2012 :8Page5of10 http://www.ijpeonline.com/content/2012/1/8
negativesweredefinedasa46,XYsubjectwiththeaverage percentYallelesignalsgreaterthanthelowerlimit,while afalsepositivewasdefinedashavingtheaveragepercent Yallelesignallessthanthelowerlimit. Converselyfor47,XYYsyndrome,theupperthreshold wasexaminedfrom49%to63%by1%increments,and sensitivityandfalsepositiverateswerecalculated.True positiveshad47,XYYkaryotypeandanaveragepercent Yallelesignalabovetheupperthreshold;any47,XYY samplewiththeaveragepercentYallelesignalbelowthe upperlimitwasscoredasfalsenegative.Truenegatives (46,XY)hadtheaveragepercentYallelesignallessthan orequaltotheupperlimit;falsepositiveshadthe averagepercentYallelesignalabovetheupperlimit. ExaminationoftheROCcurvesindicatedthata percentYallelesignalscoringthresholdof43%for47, XXYand48,XXXYsyndromesand57%for47,XYY syndromeyielded100%sensitivitywitha0%false positiverate.Combiningthetwothresholdsgavea percentYallelesignalrangeof43-57%for46,XY samples.SeparateanalysisoftheindividualXYMmarker dataandthemedianofthethreeXYMvaluesgenerated ROCcurveswhichoverlappedthecurvegeneratedwith theaverageXYMvalues;thresholdsof43%and57% 0.80 0.85 0.90 0.95 1.00 0 0 2 0 0 5 1 0 0 0 1 0 0 5 0 0 0 0 0 0 F a l s e P o s i t i v e R a t e 0.80 0.85 0.90 0.95 1.00 0.0000.0250.0500.0750.100 F a l s e P o s i t i v e R a t e A B Figure4 Receiveroperatorcharacteristiccurvesfordetectionof47,XXY(KS)and48,XXXY(A)and47,XYYsyndromes(B). Theaverageof thethreeXYMmarkerdatapointsforeachsamplewascalculatedandcomparedtothedetectionthresholds.ThethresholdfordetectingXXY andXXXYsyndromeswasvariedby1%incrementsfrom34-48%Yallelesignal;thatfordetectingXYYsyndromewasincrementedby1%from 49-63%.Thesensitivity(TP/(TP+FN))andfalsepositiverate(FP/(FP+TN))werecalculatedforeachvalueoftheappropriatethreshold.ForXXYand XXXY,truepositives(TP)haveeithera47,XXYor48,XXXYkaryotypeandaverageYallelesignallessthanthethreshold;falsenegatives(FN)have thesamekaryotypesandaverageYallelesignalgreaterthanorequaltothethreshold.Truenegatives(TN)forXXYandXXXYaresampleswitha 46,XYkaryotypeandaverageYallelesignalgreaterthanorequaltothethreshold;falsepositives(FP)havea46,XYkaryotypeandaverageYallele signalbelowthethreshold.ForXYYsyndrome,truepositiveshave47,XYYkaryotypeandaverageYallelesignalgreaterthanthethreshold;false negativeshavethesamekaryotypeandaverageYallelesignallessthanorequaltothethreshold.TruenegativesforXYYaresampleswitha46, XYkaryotypeandaverageYallelesignallessthanorequaltothethreshold;falsepositiveshavea46,XYkaryotypeandaverageYallelesignal abovethethreshold. Hager etal.InternationalJournalofPediatricEndocrinology 2012, 2012 :8Page6of10 http://www.ijpeonline.com/content/2012/1/8
allowthedetectionofKSand47,XYYsyndromewith 100%sensitivityandspecificityusingthedatafrom eithereachindividualmarkerorthemedianvalue.Detectionof48,XXYYsyndromeAsnotedabove,thepercentYallelesignalsfrom48, XXYYindividuals(n=45)and46,XYmales(n=206) showednearlycompleteoverlap(Figure3andTable1). Todistinguishthesekaryotypes,fourXAmarkerswere amplifiedbyPCRandtheresultingproductsexamined byPyrosequencing.Figure5isaplotoftheaveragepercent XalleleforthefourXAmarkersgraphedversusthesample ID.TheaveragepercentXallelesignaldifferedforthe sampleswith48,XXYYand46,XYkaryotypesandwasclose totheexpectedvaluesof50%and33.3%,respectively,based ontheknownchromosomeratios(Table2).ROCanalysis (Figure6)performedbycomp aringtheaveragepercentX alleleforthefourXAmarkerswithathresholdvarying 0.0 10.0 20.0 30.0 40.0 50.0 60.0 050100150200250 S a m p l e I D 46, XY 48, XXYY Figure5 AveragepercentXallelesignaloffourXAmarkersversussampleIDformalesampleswith46,XYand48,XXYYkaryotypes. TheaveragepercentXallelesignalistheaverageforallfourmarkersoftheratioofsignalfromtheX-chromosomespecificalleledividedbythe totalsignalfromboththeX-chromosomeandautosomespecificalleles,expressedasapercentage. 0.50 0.60 0.70 0.80 0.90 1.00 0.0000.0250.0500.0750.1000.125 F a l s e P o s i t i v e R a t e Average Median XA1 XA2 XA3 XA4 Figure6 Receiveroperatorcharacteristiccurvesfordetectionof48,XXYYsyndrome. TheaverageandmedianofthefourXAmarkerdata pointsforeachsamplewascalculated:eithertheaverage,medianorindividualmarkerdatawascomparedtothethresholdfordetecting48,XXYY syndrome.Thethresholdwasvariedby1%incrementsfrom33-52%Xallelesignal.Thesensitivity(TP/(TP+FN))andfalsepositiverate(FP/(FP+TN)) werecalculatedforeachvalueoftheappropriatethreshold.Truepositives(TP)havea48,XXYYkaryotypeandXallelesignalgreaterthanthethresho ld; falsenegatives(FN)havethesamekaryotypeandXallelesignallessthanorequaltothethreshold.Truenegatives(TN)havea46,XYkaryotypeandX allelesignallessthanorequaltothethreshold;falsepositives(FP)havea46,XYkaryotypeandXallelesignalabovethethreshold. Hager etal.InternationalJournalofPediatricEndocrinology 2012, 2012 :8Page7of10 http://www.ijpeonline.com/content/2012/1/8
from33-52%in1%incrementsindicatedthatathresholdof 43%gave100%detectionof48,XXYYkaryotypewitha0% falsepositiverate. Asaconfirmatoryapproachtodistinguishmaleswith 48,XXYYand46,XYkaryotypes,18X-linkedmarkers werePCRamplifiedandtheampliconssubjectedto PyrosequencingusingDNAfromall48,XXYYmales.The relativeallelestrengthforeachoftheX-chromosome specificmarkerswasscoredashomozygous,heterozygous, orout-of-rangeasdescribedforaTurnerSyndromeassay .Ofthe45individualswiththe48,XXYYkaryotype,43 demonstrateddefinitiveevidenceforthepresenceoftwo distinctX-chromosomes,withthenumberofheterozygous markersrangingfrom4to12outof18total.Thus,most 48,XXYYindividualseitherinheritoneX-chromosome fromeachparentorinherittwodistinctXchromosomesas aresultofnondisjunctioninmaternalmeiosisI.The remainingtwoindividualswerehomozygousforall18 markers,andtherefore,appeartohaveinheritedboth Xchromosomesfromtheirmotherduetonondisjuctionin maternalmeiosisIIorasaresultofnondisjunctionofa46, XYembryoinearlymitoticcelldivisions.Thus,forthe lattergroup,onlysignalfromtheXAmarkersdistinguished themfrom46,XYindividuals.AnalysisofCoriellsampleswitha47,XXYkaryotypeInanadditionaltestofthesexchromosomeaneuploidyassay,threeXYMmarkersweremeasuredon DNAobtainedfromimmortalizedlymphocytecultures of16individualswitha47,XXYkaryotype(Coriell InstituteofMedicalResearch).For15of16individuals,thepercentYallelesignalforallthreemarkers clusteredtightlyaroundtheexpected33.3%.OneindividualhadpercentYallelesignalsbetween53.6and 59%andisknowntohaveacomplexmosaickaryotype:47,XXY.ishX(DXZ1x2).ishY(SRYx1)/47, XYY.ishX(DXZ1x1).ishY(SRYx2)/46,XY.ish X(DXZ1x1).ishY(SRYx1),withprominentcontributionsfromboth47,XXYand47,XYYcellpopulations. Basedonthemosaicestimate,thissubjectisexpected tohavepercentYallelesignalsnear50%.AnalysisofbuccalswabsamplesAsafinaltestforassayperformance,buccalswabswere obtainedfrom29maleswithknownkaryotypes.Buccal cellDNAwasextractedandallsevenmarkersamplified byPCR.FollowingPyrosequencing,thedatafromall29 sampleswereclassifiedusingthepreviouslydescribed thresholdvaluesfortheXYMandXAmarkers.Table3 presentstheaggregatestatisticaldatafortheaverage allelesignalofthebuccalswabsamplesgroupedby karyotype.Buccalswabsamplesdemonstrated100% sensitivityandspecificityfordetectionofmalesex chromosomeaneuploidies.DiscussionWereportthedevelopmentofarapid,high-throughput Pyrosequencingassayfordetectingsexchromosome aneuploidiesinmales.Theassayinitiallyinterrogates threeXYMmarkers,yieldingthepercentYallelesignal whichisdirectlyrelatedtotheY:Xchromosomeratio. Next,todistinguish46,XYand48,XXYYkaryotypes,the assayutilizesfourXAmarkerstodeterminetheX:A ratio.Usingthisapproach,ourassayidentifiesmaleswith 47,XXY,47,XYY,48,XXXYand48,XXYYkaryotypesat 100%sensitivityandspecificity(Table4). Previousstudiesoftheparentaloriginofthesex chromosomesinmaleswith48,XXYYarelimitedtoa totalofeightindividuals[17-21].Thesestudies Table3StatisticalvaluescalculatedfromtheaveragepercentallelesignalsoftheXYMandXAmarkersetsforbuccal swabsamplesgroupedtogetherbykaryotypeKarytoype47,XXY(n=8)47,XYY(n=3)46,XY(n=5)48,XXYY(n=13) MarkerSetAverageY AlleleXYM AverageX AlleleXA AverageY AlleleXYM AverageX AlleleXA AverageY AlleleXYM AverageX AlleleXA AverageY AlleleXYM AverageX AlleleXA Average184.108.40.206.350.6220.127.116.11 Median35.051.518.104.22.1687.750.352.1 StdDev0.91.70.20.90.81.31.01.9 Maximum36.854.365.437.351.639.552.156.3 Minimum34.050.265.035.649.636.648.049.7 Table4Sensitivityandfalsepositiveratefordetectionof sexchromosomeaneuploidiesinmalesKaryotypeTotalSamplesSensitivityFalsePositiveRate 47,XXY(KS)65100%0% 47,XYY29100%0% 48,XXXY4100%0% 48,XXYY58100%0%CombinationofresultsforDNAsisolatedfrombuccalswabs(n=29)or obtainedfromColoradoChildren sHospital,UCDavisMINDInstitute,Children s HospitalBoston,YaleUniversityandCoriellInstitute(n=338).OneCoriell samplewasomittedfromthistableduetoitscomplicatedmosaickaryotype: 47,XXY[ 17 ].ishX(DXZ1x2).ishY(SRYx1)/47,XYY.ishX(DXZ1x1).ishY (SRYx2)/46,XY[ 5 ].ishX(DXZ1x1).ishY(SRYx1).Hager etal.InternationalJournalofPediatricEndocrinology 2012, 2012 :8Page8of10 http://www.ijpeonline.com/content/2012/1/8
concludedthattheextrasexchromosomesarepaternally derived,resultingfromtwosequentialnondisjunction eventsinmeiosisIandIIofspermatogenesis.Ourdata for96%ofsubjectswith48,XXYY(n=43)areconsistent withthismechanismsincetheDNAsamples demonstratedheterozygosityforbetween4and12ofa total18X-linkedbiallelicSNPmarkers.However,the datacannotruleoutanalternativemechanismwhereby theadditionalXchromosomeismaternallyderivedfrom nondisjunctioninmeiosisIofoogenesisandthe supernumeraryYisduetonondisjunctioninmeiosisII ofspermatogenesis.Onlydetailedmoleculargenetic analysisoftheparentsof48,XXYYmalescanascertain therelativecontributionofthesetwomechanisms;still, thestatisticallikelihoodofanXaneuploidoocytebeing fertilizedbyaYaneuploidspermisquitelow.The remaining4%ofsubjectswith48,XXYY(n=2)were showntohaveidenticalXchromosomesduetocomplete homozygosityofthe18X-linkedmarkersandthuslikely resultfromnondisjunctionduringearlymitoticdivisions ofa46,XYembryo.Alternatively,butlesslikely,this subsetofindividualsmayresultfromnondisjunctionin meiosisIIofbothmaternalandpaternalgametes.The currentstudyhasalargeenoughpopulation(n=45)to detectthisnovelmechanismforthechromosomalorigin ofthesupernumerarysexchromosomesin48,XXYY males. OurPyrosequencingbasedassayisrobustandreadily interpretableallowingthereliabledetectionofmalesex chromosomeaneuploidieswith100%sensitivityand specificity.Thisparticularmethodologyservesasa rapid,high-throughputscreen,andtheaccuracyof detectionforKSandothersexchromosomeaneuploidies translatestoanextremelylowlikelihoodofdiscrepant karyotypicanalysisifutilizedforconfirmation.Theassay maybecompletedin8 10hrs.whichisconsiderably fasterthanthetimerequiredforeitherfluorescentinsitu hybridization(FISH)orkaryotypeanalysis.Individuals withKSmaypresentclinicallyatmanypointsduring theirlifetime,andyet,becauseofvariableandoften subtlephenotype,theyarenotrecognizedandin mostcases,neverdiagnosed.Thecurrentassay providesanon-invasivemoleculartestapplicablefor rapiddiagnosis,thusallowingforearlierassessmentsand interventionsinallfacetsoftherapyforKS,47,XYY,48, XXYYand48,XXXY,includingandrogenreplacement andcognitiveandbehavioraltreatments. FormalechildrensuspectedofKSoranothersex chromosomeaneuploidy,theabilitytomakethe diagnosisusingDNAisolatedfrombuccalswabsisan advantageoverinvasive,oftentraumatic,bloodtesting. Diagnosisduringinfancy/childhood,especiallyforKS, allowsforearlyinterventionalspeech/languagetherapy andeducationalplanning,aswellaspromotionof physicalactivitytoinhibitthedevelopmentofdyspraxia. Endocrinemonitoringandearlymanagementcanbe institutedtoeventuallysupport puberty,preservefertility, anddeterminethetimingofandrogenreplacement. Withrespectto47,XYYsyndrome,rapidandefficientdetectionsimilarlypermitsinitiationofappropriatecognitive andbehavioraltherapy.Currenttrialsofpharmaceuticals forgeneraldevelopmentaldisordersinmalechildrenthat overlapwithKSandothersupernumeraryXchromosome syndromesmayalsobenefitfromdiagnosticspecificityfor theserelevantaneuploidies. EvenmakingthedelayeddiagnosisofKSorother sexchromosomeaneuploidiesinadulthoodoffers specifictreatmentgoalsfortheirrelatedcomplications. KSisoneofthemostfrequentcausesofmale infertility.Foradultmalesbeingevaluatedfor failuretoconceive,makingthisdiagnosisearlieroffers specificandbetteroptionstopreservefertility, andthisrapidmethodologymaydecreasethestress andanxietyassociatedwithwaitingforthediagnosisof KS(orothersexchromosomeaneuploidy)bykaryotyping. Aswithmalechildren,makingthediagnosisofKSin adulthoodisalsoimportantforinstitutingspecific endocrinetherapiestopreventgynecomastiaand osteopenia. Theclinicalapplicationofthissensitiveandspecific Pyrosequencingbasedassaywillenabletherapid,efficient andhigh-throughputdetectionofsexchromosome aneuploidiesinmalesandallowforearly,appropriate assessmentandtherapeuticinterventionsforindividuals withthesecommonbutunder-diagnosedgenetic conditions.Competinginterests KarlHager,KoriJennings&SeiyuHosonoareemployeesofJSGenetics,Inc.. KarlHager,SeiyuHosono,JeffreyR.Gruen,ScottA.Rivkees,andHenryM. RinderholdequityinterestinJSGenetics,Inc..SusanHowellandNicoleR. Tartagliahavenocompetinginterests. Authordetails1JSGenetics,Inc,2ChurchSt.South,B-05,NewHaven,CT06519,USA.2Children sHospitalColorado,Aurora,CO80045,USA.3YaleChildHealth ResearchCenter,YaleUniversitySchoolofMedicine,NewHaven,CT06520, USA.4DepartmentofPediatrics,YaleUniversitySchoolofMedicine,New Haven,CT06520,USA.5DepartmentofGenetics,YaleUniversitySchoolof Medicine,NewHaven,CT06520,USA.6InvestigativeMedicineProgram,Yale UniversitySchoolofMedicine,NewHaven,CT06520,USA.7Departmentof Pediatrics,UniversityofFlorida,Gainesville,FL32610,USA.8Departmentof LaboratoryMedicine,YaleUniversity,NewHaven,CT06510,USA. Authors contributions KHcontributedtostudydesign,developedthehypothesis,analyzeddata,and wrotethemanuscript;KJanalyzeddataandcontributedtowritingofthe manuscript;SHcontributedtostudydesignandwritingofthemanuscript;SH contributedtostudydesign,writingofth emanuscript,andcollectionofpatient samples;JGcontributedtostudydesignandwritingofthemanuscript;SR contributedtostudydesignandwriting ofthemanuscript;NTcontributedto studydesign,writingofthemanuscript,andcollectionofpatientsamples;HR developedthehypothesis,analyzeddat a,andcontributedtostudydesignand writingthemanuscript.Allauthorsrea dandapprovedthefinalmanuscript.Hager etal.InternationalJournalofPediatricEndocrinology 2012, 2012 :8Page9of10 http://www.ijpeonline.com/content/2012/1/8
Received:3April2012Accepted:23April2012 Published:23April2012 References1.VisootsakJ,GrahamJM: Klinefeltersyndromeandothersexchromosome aneuploidies. OrphanetJRareDiseases 2006, 1: 42. 2.RLNussbaumRRMcInessHFWillard2007ClinicalCytogenetics:Disordersofthe AutosomesandtheSexChromosomesInThompson&ThompsonGenetics inMedicine,SeventhEditionSaundersElsevierPhiladelphia105107Nussbaum RL,McInessRR,WillardHF: ClinicalCytogenetics:Disordersofthe AutosomesandtheSexChromosomes. In Thompson&ThompsonGenetics inMedicine ,SeventhEdition.Philadelphia:SaundersElsevier;2007:105 107. 3.TuttelmanF,GromollJ: NovelgeneticaspectsofKlinefelter ssyndrome. MolecHumanReprod 2010, 16: 386 395. 4.CoffeeB,KeithK,AlbizuaI,MaloneT,MowreyJ,ShermanSL,WarrenST: IncidenceoffragileXsyndromebynewbornscreeningformethylated FMR1DNA. AmJHumGenet 2009, 85: 503 514. 5.RossJL,ZegerMPD,KushnerH,ZinnAR,RoeltgenDP: AnextraXorY chromosome:contrastingthecognitiveandmotorphenotypesin childhoodinboyswith47,XYYsyndromeor47,XXYKlinefelter syndrome. DevDisabilResRev 2009, 15: 309 317. 6.BojesenA,JuulS,GravholtCH: Prenatalandpostnatalprevalenceof Klinefeltersyndrome:anationalregistrystudy. JClinEndocrinolMetab 2003, 88: 622 626. 7.StockholmK,JuulS,GravholtCH: Diagnosisandmortalityin47,XYY persons:aregistrystudy. OrphanetJRareDis 2010, 5: 15. 8.TartagliaN,HowellS,AyariN,D EpagnierC,ZeitlerP: 48,XXYY,48,XXXYand 49,XXXXYsyndromes:NotjustvariantsofKlinefeltersyndrome. Acta Paediatr 2011, 100: 851 860. 9.TartagliaN,DavisS,HenchA,NimishakavS,BeauregardR,ReynoldsA, FentonL,AlbrechtL,RossJ,VisootsakJ,HansenR,HagermanR: Anewlook atXXYYsyndrome:medicalandpsychologicalfeatures. AmJMedGenetA 2008, 146A: 1509 1522. 10.HosonoS,FaruqiAF,DeanFB,DuY,SunZ,WuX,DuJ,KingsmoreSF, EgholmM,LaskenRS: Unbiasedwhole-genomeamplificationdirectly fromclinicalsamples. GenomeRes 2003, 13: 954 964. 11.RossMT,GrafhamDV,CoffeyAJ,SchererS,McLayK,MuznyD,PlatzerM, HowellGR,BurrowsC,BirdCP,FrankishA,LovellFL,HoweKL,AshurstJL, FultonRS,SudbrakR,WenG,JonesMC,HurlesME,AndrewsTD,ScottCE, SearleS,RamserJ,WhittakerA,DeadmanR,CarterNP,HuntSE,ChenR, CreeA,GunaratneP,HavlakP,HodgsonA,MetzkerML,RichardsS,ScottG, SteffenD,SodergrenE,WheelerDA,WorleyKC,AinscoughR,AmbroseKD, Ansari-LariMA,AradhyaS,AshwellRI,BabbageAK,BagguleyCL,BallabioA, BanerjeeR,BarkerGE,BarlowKF,BarrettIP,BatesKN,BeareDM,BeasleyH, BeasleyO,BeckA,BethelG,BlechschmidtK,BradyN,Bray-AllenS, BridgemanAM,BrownAJ,BrownMJ,BonninD,BrufordEA,BuhayC,Burch P,BurfordD,BurgessJ,BurrillW,BurtonJ,ByeJM,CarderC,CarrelL,Chako J,ChapmanJC,ChavezD,ChenE,ChenG,ChenY,ChenZ,ChinaultC, CiccodicolaA,ClarkSY,ClarkeG,CleeCM,CleggS,Clerc-BlankenburgK, CliffordK,CobleyV,ColeCG,ConquerJS,CorbyN,ConnorRE,DavidR, DaviesJ,DavisC,DavisJ,DelgadoO,DeshazoD,DhamiP,DingY,DinhH, DodsworthS,DraperH,Dugan-RochaS,DunhamA,DunnM,DurbinKJ, DuttaI,EadesT,EllwoodM,Emery-CohenA,ErringtonH,EvansKL,Faulkner L,FrancisF,FranklandJ,FraserAE,GalgoczyP,GilbertJ,GillR,GlcknerG, GregorySG,GribbleS,GriffithsC,GrocockR,GuY,GwilliamR,HamiltonC, HartEA,HawesA,HeathPD,HeitmannK,HennigS,HernandezJ,Hinzmann B,HoS,HoffsM,HowdenPJ,HuckleEJ,HumeJ,HuntPJ,HuntAR,IsherwoodJ,JacobL,JohnsonD,JonesS,deJongPJ,JosephSS,KeenanS, KellyS,KershawJK,KhanZ,KioschisP,KlagesS,KnightsAJ,KosiuraA,KovarSmithC,LairdGK,LangfordC,LawlorS,LevershaM,LewisL,LiuW,LloydC, LloydDM,LoulsegedH,LovelandJE,LovellJD,LozadoR,LuJ,LyneR,MaJ, MaheshwariM,MatthewsLH,McDowallJ,McLarenS,McMurrayA,MeidlP, MeitingerT,MilneS,MinerG,MistrySL,MorganM,MorrisS,MllerI, MullikinJC,NguyenN,NordsiekG,NyakaturaG,O'DellCN,OkwuonuG, PalmerS,PandianR,ParkerD,ParrishJ,PasternakS,PatelD,PearceAV, PearsonDM,PelanSE,PerezL,PorterKM,RamseyY,ReichwaldK,RhodesS, RidlerKA,SchlessingerD,SchuelerMG,SehraHK,Shaw-SmithC,ShenH, SheridanEM,ShownkeenR,SkuceCD,SmithML,SotheranEC,Steingruber HE,StewardCA,StoreyR,SwannRM,SwarbreckD,TaborPE,TaudienS, TaylorT,TeagueB,ThomasK,ThorpeA,TimmsK,TraceyA,TrevanionS, TromansAC,d'UrsoM,VerduzcoD,VillasanaD,WaldronL,WallM,WangQ, WarrenJ,WarryGL,WeiX,WestA,WhiteheadSL,WhiteleyMN,Wilkinson JE,WilleyDL,WilliamsG,WilliamsL,WilliamsonA,WilliamsonH,WilmingL, WoodmanseyRL,WrayPW,YenJ,ZhangJ,ZhouJ,ZoghbiH,ZorillaS,Buck D,ReinhardtR,PoustkaA,RosenthalA,LehrachH,MeindlA,MinxPJ,Hillier LW,WillardHF,WilsonRK,WaterstonRH,RiceCM,VaudinM,CoulsonA, NelsonDL,WeinstockG,SulstonJE,DurbinR,HubbardT,GibbsRA,BeckS, RogersJ,BentleyDR: TheDNAsequenceofthehumanXchromosome. Nature 2005, 434: 325 337. 12.SkaletskyH,Kuroda-KawaguchiT,MinxPJ,CordumHS,HillierL,BrownLG, ReppingS,PyntikovaT,AliJ,BieriT,ChinwallaA,DelehauntyA,Delehaunty K,DuH,FewellG,FultonL,FultonR,GravesT,HouSF,LatrielleP,LeonardS, MardisE,MaupinR,McPhersonJ,MinerT,NashW,NguyenC,OzerskyP, PepinK,RockS,RohlfingT,ScottK,SchultzB,StrongC,Tin-WollamA,Yang SP,WaterstonRH,WilsonRK,RozenS,PageDC: Themale-specificregionof thehumanYchromosomeisamosaicofdiscretesequenceclasses. Nature 2003, 423: 825 837. 13.AltschulSF,GishW,MillerW,MyersEW,LipmanDJ: Basiclocalalignment searchtool. JMolBiol 1990, 215: 403 410. 14.FlicekP,AmodeMR,BarrellD,BealK,BrentS,ChenY,ClaphamP,CoatesG, FairleyS,FitzgeraldS,GordonL,HendrixM,HourlierT,JohnsonN,KhriA, KeefeD,KeenanS,KinsellaR,KokocinskiF,KuleshaE,LarssonP,LongdenI, McLarenW,OverduinB,PritchardB,RiatHS,RiosD,RitchieGR,RuffierM, SchusterM,SobralD,SpudichG,TangYA,TrevanionS,VandrovcovaJ, VilellaAJ,WhiteS,WilderSP,ZadissaA,ZamoraJ,AkenBL,BirneyE, CunninghamF,DunhamI,DurbinR,Fernndez-SuarezXM,HerreroJ, HubbardTJ,ParkerA,ProctorG,VogelJ,SearleSM: Ensembl2011. Nucleic AcidsRes 2011, 39(Databaseissue): D800 D806. 15.Fakhrai-RadH,PourmandN,RonaghiM: Pyrosequencing:anaccurate detectionplatformforsinglenucleotidepolymorphisms. HumMutat 2002, 19: 479 485. 16.RivkeesSA,HagerK,HosonoS,WiseA,LiP,RinderHM,GruenJR: Ahighly sensitive,high-throughputassayforthedetectionofTurnersyndrome. J ClinEndocrinolMetab 2011, 96: 699 705. 17.Lorda-SanchezI,BinkertF,HinkelKG,MoserH,RosenkranzW,MaechlerM, SchinzelA: Uniparentaloriginofsexchromosomepolysomies. HumHered 1992, 42: 193 197. 18.LealCA,BelmontJW,NachtmanR,CantuJM,MedinaC: Parentaloriginof theextrachromosomesinpolysomyX. HumGenet 1994, 94: 423 426. 19.IitsukaY,BockA,NguyenDD,Samango-SprouseCA,SimpsonJL,Bischoff FZ: EvidenceofskewedX-chromosomeinactivationin47,XXYand48, XXYYKlinefelterpatients. AmJMedGenet 2001, 98: 25 31. 20.HilligU,HooJJ: Acaseof48,XXYY paternaloriginoftheextraX chromosome. Humangenetik 1974,25: 159 161. 21.RinaldiA,ArchidiaconoN,RocchiM,FilippiG: Additionalpedigree supportingthefrequentoriginofXXYYfromconsecutivemeioticnondisjunctioninpaternalgametogenesis. JMedGenet 1979, 16: 225 226. 22.AbramskyL,ChappleJ: 47,XXY(Klinefeltersyndrome)and47,XYY: estimatedratesandindicationforpostnataldiagnosiswithimplications forprenatalcounseling. PrenatDiagn 1997, 17: 363 368. 23.RadicioniAF,DeMarcoE,GianfrilliD,GranatoS,GandiniL,IsidoriAM,Lenzi A: StrategiesandadvantagesofearlydiagnosisinKlinefelter'ssyndrome. MolHumReprod 2010, 16: 434 440. 24.LanfrancoF,KamischkeA,ZitamannM,NieschlagE: Klinefelter ssyndrome. Lancet 2004, 364: 273 283. 25.FerhiK,AvakianR,GriveauJF,GuilleF: Ageasonlypredictivefactorfor successfulspermrecoveryinpatientswithKlinefelter ssyndrome. Andrologia 2009, 41: 84 87.doi:10.1186/1687-9856-2012-8 Citethisarticleas: Hager etal. : Moleculardiagnostictestingfor Klinefeltersyndromeandothermalesexchromosomeaneuploidies. InternationalJournalofPediatricEndocrinology 2012 2012 :8.Hager etal.InternationalJournalofPediatricEndocrinology 2012, 2012 :8Page10of10 http://www.ijpeonline.com/content/2012/1/8
!DOCTYPE art SYSTEM 'http:www.biomedcentral.comxmlarticle.dtd'
ui 1687-9856-2012-8ji 1687-9856fm dochead Researchbibl title p Molecular diagnostic testing for Klinefelter syndrome and other male sex chromosome aneuploidiesaug au id A1 ca yes snm Hagerfnm Karlinsr iid I1 email email@example.comA2 JenningsKorik.firstname.lastname@example.orgA3 HosonoSeiyus.email@example.comA4 HowellSusanI2 Susan.Howell@childrenscolorado.orgA5 Gruenmi RJeffreyI3 I4 I5 I6 firstname.lastname@example.orgA6 pa RivkeesAScottI7 email@example.comA7 TartagliaRNicoleNicole.Tartaglia@childrenscolorado.orgA8 RinderMHenryI8 firstname.lastname@example.org ins JS Genetics, Inc, 2 Church St. South, B-05, New Haven, CT, 06519, USAChildren’s Hospital Colorado, Aurora, CO, 80045, USAYale Child Health Research Center, Yale University School of Medicine, New Haven, CT, 06520, USADepartment of Pediatrics, Yale University School of Medicine, New Haven, CT, 06520, USADepartment of Genetics, Yale University School of Medicine, New Haven, CT, 06520, USAInvestigative Medicine Program, Yale University School of Medicine, New Haven, CT, 06520, USADepartment of Pediatrics, University of Florida, Gainesville, FL, 32610, USADepartment of Laboratory Medicine, Yale University, New Haven, CT, 06510, USAsource International Journal of Pediatric Endocrinologyissn 1687-9856pubdate 2012volume 2012issue 1fpage 8url http://www.ijpeonline.com/content/2012/1/8xrefbib pubidlist pubid idtype doi 10.1186/1687-9856-2012-8pmpid 22524164history rec date day 3month 4year 2012acc 2342012pub 2342012cpyrt 2012collab Hager et al.; licensee BioMed Central Ltd.note This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.kwdg kwd PyrosequencingSex chromosome aneuploidyKlinefelter (47,XXY) syndrome47,XYY syndrome48,XXYY syndrome48,XXXY syndromeMale infertilityabs sec st AbstractBackgroundMale sex chromosome aneuploidies are underdiagnosed despite concomitant physical and behavioral manifestations.ObjectiveTo develop a non-invasive, rapid and high-throughput molecular diagnostic assay for detection of male sex chromosome aneuploidies, including 47,XXY (Klinefelter), 47,XYY, 48,XXYY and 48,XXXY syndromes.MethodsThe assay utilizes three XYM and four XA markers to interrogate Y:X and X:autosome ratios, respectively. The seven markers were PCR amplified using genomic DNA isolated from a cohort of 323 males with aneuploid (n = 117) and 46,XY (n = 206) karyotypes. The resulting PCR products were subjected to Pyrosequencing, a quantitative DNA sequencing method.ResultsReceiver operator characteristic (ROC) curves were used to establish thresholds for the discrimination of aneuploid from normal samples. The XYM markers permitted the identification of 47,XXY, 48,XXXY and 47,XYY syndromes with 100% sensitivity and specificity in both purified DNA and buccal swab samples. The 48,XXYY karyotype was delineated by XA marker data from 46,XY; an X allele threshold of 43% also permitted detection of 48,XXYY with 100% sensitivity and specificity. Analysis of X chromosome-specific biallelic SNPs demonstrated that 43 of 45 individuals (96%) with 48,XXYY karyotype had two distinct X chromosomes, while 2 (4%) had a duplicate X, providing evidence that 48,XXYY may result from nondisjunction during early mitotic divisions of a 46,XY embryo.ConclusionsQuantitative Pyrosequencing, with high-throughput potential, can detect male sex chromosome aneuploidies with 100% sensitivity.bdy IntroductionKlinefelter syndrome (KS, also known as 47,XXY) and 47,XYY syndrome are the two most common sex chromosome aneuploidies in humans with prevalence of approximately 1 in 600–1000 males abbrgrp abbr bid B1 1B2 2B3 3B4 4. Individuals with KS are usually tall adolescents and adults who have hypergonadotrophic hypogonadism with small testicles. However, the KS phenotype is highly variable and individuals may not show these physical features to a degree that distinguishes them from the general male population. Males with 47,XYY are also taller than average, but in contrast to KS, they usually do not have phenotypic characteristics to differentiate them from 46,XY males. Compared to 46,XY males, individuals with KS or 47,XYY syndrome exhibit a greater incidence of behavioral problems, psychiatric disorders and neuropsychological characteristics including developmental delays and difficulties in cognitive, verbal and social skills B5 5. Yet individuals with both syndromes often fail to be ascertained. Newborn screening studies estimate that only 25% of all individuals with KS, and 10% of all individuals with 47,XYY are diagnosed during their lifetime B6 6B7 7.More complex male sex chromosome aneuploidies, such as 48,XXYY and 48,XXXY, are less common than KS with prevalences ranging from 1 in 18,000 to 1 in 100,000 or greater 1. While some phenotypic characteristics of 48,XXYY and 48,XXXY syndromes overlap with KS, the unique and significant differences in physical appearance, cognitive function, social and adaptive skills observed in affected individuals differentiate these aneuploidies from KS B8 8B9 9.The gold standard for detection of chromosome aneuploidies is karyotype analysis, an invasive, time-consuming and labor-intensive process. Yet despite the widespread availability of karyotyping, most males with sex chromosome aneuploidy are never diagnosed during their lifetime 67. Thus, the development of more convenient methods for detection of sex chromosome aneuploidies should facilitate identification of these individuals, allowing them to receive early evaluation and therapeutic intervention as indicated. To address this need, we developed a two-stage Pyrosequencing based assay which measures Y:X and X:autosome chromosome ratios. Using this approach, we demonstrated 100% sensitivity in the identification of males with sex chromosome aneuploidy.Materials & methodsDNA samplesDe-identified karyotype-confirmed DNA samples from individuals with male sex chromosome aneuploidies (n = 117) were obtained from Children's Hospital Colorado and the UC Davis MIND Institute (Dr. Flora Tassone). Additional de-identified karyotype-confirmed DNA samples from subjects with 45,X (n = 1), 46,XX (n = 4), 47,XXX (n = 11), and 46,XY (n = 206) were provided by the above sources, plus the Yale Cytogenetics Lab (Dr. Peining Li) and the Genetics Diagnostic Lab of Children’s Hospital Boston (Dr. Bai-Lin Wu). Before use, the DNA samples were diluted 20-fold with nuclease-free water. The concentration of diluted DNA was determined by real time PCR using the human specific probe WIAF699 as described B10 10. Only samples with a concentration of diluted DNA ≥1 ng/μl were used as templates for PCR of the XYM and XA markers (see below).DNA isolation from buccal swabsBuccal swabs were obtained from patients of Children’s Hospital Colorado after informed consent. DNA was isolated from buccal cells using the Qiagen EZ1 robot and EZ1 DNA tissue kit according to the manufacturer’s protocol. Extracted DNA was quantified by real time PCR as above.Assay designPyrosequencing (PSQ) assays were designed to interrogate two types of markers. The first class of markers, designated XYM, consisted of regions of the X and Y chromosomes with nearly identical sequence that differ by a chromosome-specific biallelic single nucleotide polymorphism, such that one allele is present only on the X chromosome and the other allele is located on the Y chromosome. Candidate sequences were identified by examining closely related genes present on both X and Y chromosomes outside of the terminal pseudoautosomal regions (see Table tblr tid T1 1 of reference B11 11 and Table T2 2 of reference B12 12). BLAST B13 13 searches of the human reference genome sequence were used to confirm a single match to the X and Y chromosomes for all sequences entered into the PSQ assay design software (version 1.0.6).table Table 1caption b Statistical values calculated from the percent Y allele signals of the three XYM markers for samples grouped together by karyotypetgroup align left cols 16 colspec right colname c1 colnum 1 colwidth 1* center c2 2 c3 3 c4 4 c5 5 c6 6 c7 7 c8 8 c9 9 c10 10 c11 11 c12 12 c13 13 c14 14 c15 15 c16 thead valign top row rowsep entry Karyotypenameend namest 47, XXY (n = 42)47, XYY (n = 26)48, XXXY (n = 4)48, XXYY (n = 45)46, XY (n = 206)MarkerXYM1XYM2XYM3XYM1XYM2XYM3XYM1XYM2XYM3XYM1XYM2XYM3XYM1XYM2XYM3tbody Average32.333.333.763.762.564.624.426.726.047.448.149.348.249.749.3Median32.333.433.763.662.264.724.126.725.747.648.049.448.249.849.2Std Dev1.532.561.391.551.530.831.540.570.901.172.701.151.461.611.55Maximum38.940.639.067.865.966.826.427.327.350.658.351.851.953.253.3Minimum30.127.931.061.557.862.323.025.925.345.422.214.171.124.142.8Table 2Statistical values calculated from the percent X allele signals of the four XA markers for samples grouped together by karyotypeKaryotype48, XXYY (n = 45)46, XY (n = 206)MarkerXA1XA2XA3XA4XA1XA2XA3XA4Average56.854.148.550.442.335.333.032.0Median56.454.048.950.8126.96.36.1991.7Std Dev1.742.572.433.472.512.032.993.56Maximum59.7188.8.131.520.242.637.251.3Minimum52.249.535.343.835.527.40.020.8The second class of markers, designated XA, represent regions of the X chromosome that are nearly identical with an autosome except for a single chromosome-specific base. Candidate sequences for assay design were identified by BLAST searching the human genome reference sequence with the set of all X-chromosome transcripts obtained from the ENSEMBL database B14 14. High scoring matches where at least 200 bases were >95% identical with one locus on the X-chromosome and one on an autosome were used to generate consensus sequences for assay design by the PSQ software.PCR and extension primers for high scoring assays were synthesized using standard methods by the W. M. Keck Foundation Biotechnology Resource Lab of Yale University. One of the PCR primers for each assay was labeled at the 5´ end with biotin. For all assays, the extension primer had the same orientation as the forward PCR primer and is complementary to the biotinylated template strand generated with the reverse PCR primer.PCR and pyrosequencingA minimum of 2.5 ng genomic DNA was used as template in a 25 μl PCR reaction. Each PCR reaction contained 1 X Hotstar buffer (Qiagen), 2.5 mM MgClsub 2, 200 μM each dNTP, 1 μM each PCR primer, 0.5 U Hotstar Taq Plus (Qiagen). Reactions were performed as follows: initial incubation of 5 min at 95°C; followed by 45 cycles of 30 sec at 95°C, 45 sec at 56°C, and 60 sec at 72 °C; then 5 min at 72 °C and a final hold at 4°C. Upon completion of PCR, the biotinylated template strand was purified using Streptavidin-Sepharose and the Filter Prep tool (Qiagen) according to the manufacturer’s instructions. The resulting single stranded template was annealed to the appropriate extension primer and Pyrosequencing was performed using Pyromark Q96 reagents and PSQ96MA instrument (Qiagen). The allele percentage was calculated by the PSQ software (version 2.1) and exported for analysis by Microsoft Excel.ResultsPrinciple of assayThe assay measures both Y:X and X:A (X:Autosome) chromosome ratios by Pyrosequencing, a quantitative short-read DNA sequencing technology B15 15. For the first step, three XYM loci are PCR amplified with specific primer pairs and the resulting amplicons subjected to Pyrosequencing, yielding the percent of Y-chromosome-specific allele signal for each locus and hence, the ratio of the Y and X chromosomes. Figure figr fid F1 1 shows Pyrosequencing data using the XYM3 marker with DNA from a 46,XX female (A), 46,XY male (B), a 47,XXY individual (C), and a 47,XYY subject (D). The percent Y allele signal has close agreement with the value predicted for each karyotype. The locations of the three XYM markers on the X and Y chromosomes are shown in Figure F2 2.fig Figure 1Pyrograms for DNA from a 46,XX female (A), a 46,XY male (B), a 47,XXY KS male (C), and a 47,XYY male (D) using the XYM3 assay.text
Pyrograms for DNA from a 46,XX female (A), a 46,XY male (B), a 47,XXY KS male (C), and a 47,XYY male (D) using the XYM3 assay. The box encloses the two nucleotide dispensations which define the C/T SNP; the C-allele is derived from the X-chromosome and the T-allele is from the Y-chromosome. The percent of each allele is shown in the shaded box above each pyrogram. The y-axis depicts the intensity of light signal in arbitrary units and the x-axis shows the time of addition of Pyrosequnecing enzymes (E), substrates (S), and each individual nucleotide dispensation (A, C, G, or T).
graphic file 1687-9856-2012-8-1 hint_layout double Figure 2Locations of the XYM markers on the X and Y chromosomes.
Locations of the XYM markers on the X and Y chromosomes. X and Y chromosome ideograms are drawn to scale using data from the UCSC genome browser. X chromosome is 154.9 Mb and Y chromosome is 57.8 Mb.
1687-9856-2012-8-2 In the second step of the assay, Pyrosequencing of the four XA markers determines the X:autosome (X:A) ratio, which permits differentiation between individuals with 46,XY and 48,XXYY karyotypes.Overall performance of XYM markersTo evaluate the ability of the three XYM markers to detect sex chromosome aneuploidies, PCR and Pyrosequencing were performed on 339 DNA samples from females (n = 16) and males (n = 323), with the technician blinded to each individual’s karyotype. Following completion of Pyrosequencing, the karyotype of each sample was matched to the data for all three markers. All samples from phenotypic females, including individuals with a 46,XX karyotype (n = 4) and those with sex chromosome aneuploidies (45,X, n = 1 and 47,XXX, n = 11), did not display detectable Y allele for any of the three XYM markers (maximum Y allele signal of 1.9%).Data generated with the three XYM markers were analyzed for the 323 DNA samples from males with karyotype-confirmed sex chromosome aneuploidies (n = 117) or 46,XY (n = 206). Scatter plots of the percent Y allele signal for both the XYM2 and XYM3 markers versus the percent Y allele signal of the XYM1 marker are shown in Figure F3 3. For all three XYM markers, the data for individuals with the 48,XXXY, 47,XXY, and 47,XYY karyotypes were tightly clustered and distinguishable from males with a 46,XY karyotype. As expected from the known Y:X chromosome ratio, the percent Y allele signals for the subjects with 48,XXYY karyotype overlapped with those for the 46,XY males. The percent Y allele signal for both XYM2 and XYM3 was strongly correlated with XYM1, with correlation coefficients (rsup 2) of 0.90 and 0.94, respectively. Table 1 summarizes the statistical data calculated for the measured percent Y allele signal of each marker for samples grouped according to karyotype; the average percent Y allele signal for each group was close to the predicted value based on the known karyotype.Figure 3Percent Y allele signal of XYM2 (A) and XYM3 (B) plotted against the percent Y allele signal of XYM1 for 323 DNA samples from male subjects grouped by karyotype.
Percent Y allele signal of XYM2 (A) and XYM3 (B) plotted against the percent Y allele signal of XYM1 for 323 DNA samples from male subjects grouped by karyotype. For each marker, the percent Y allele signal is the ratio of signal from the Y-chromosome specific allele divided by the total signal from both the Y- and X-chromosome specific alleles, expressed as a percentage.
1687-9856-2012-8-3 Detection of 47,XXY (KS), 48,XXXY and 47,XYY syndromesTo identify 47,XXY, 48,XXXY, or 47,XYY karyotypes, receiver operator characteristic (ROC) curves were constructed by varying the percent Y allele signal lower and upper thresholds for samples scored as normal 46,XY karyotype (Figure F4 4). For this analysis, the average percent Y allele signal for the three XYM markers was calculated; the lower threshold was increased from 34% to 48% by 1% increments while sensitivity and false positive rates for detecting 47,XXY (KS) and 48,XXXY karyotypes were calculated. All samples with either 47,XXY or 48,XXXY karyotypes and average percent Y allele signals less than the lower threshold value were classified as true positives. False negative samples had the same karyotypes and the average percent Y allele signal above the threshold. True negatives were defined as a 46,XY subject with the average percent Y allele signals greater than the lower limit, while a false positive was defined as having the average percent Y allele signal less than the lower limit.Figure 4Receiver operator characteristic curves for detection of 47,XXY (KS) and 48,XXXY (A) and 47,XYY syndromes (B).
Receiver operator characteristic curves for detection of 47,XXY (KS) and 48,XXXY (A) and 47,XYY syndromes (B). The average of the three XYM marker data points for each sample was calculated and compared to the detection thresholds. The threshold for detecting XXY and XXXY syndromes was varied by 1% increments from 34-48% Y allele signal; that for detecting XYY syndrome was incremented by 1% from 49-63%. The sensitivity (TP/(TP + FN)) and false positive rate (FP/(FP + TN)) were calculated for each value of the appropriate threshold. For XXY and XXXY, true positives (TP) have either a 47,XXY or 48,XXXY karyotype and average Y allele signal less than the threshold; false negatives (FN) have the same karyotypes and average Y allele signal greater than or equal to the threshold. True negatives (TN) for XXY and XXXY are samples with a 46,XY karyotype and average Y allele signal greater than or equal to the threshold; false positives (FP) have a 46,XY karyotype and average Y allele signal below the threshold. For XYY syndrome, true positives have 47,XYY karyotype and average Y allele signal greater than the threshold; false negatives have the same karyotype and average Y allele signal less than or equal to the threshold. True negatives for XYY are samples with a 46,XY karyotype and average Y allele signal less than or equal to the threshold; false positives have a 46,XY karyotype and average Y allele signal above the threshold.
1687-9856-2012-8-4 Conversely for 47,XYY syndrome, the upper threshold was examined from 49% to 63% by 1% increments, and sensitivity and false positive rates were calculated. True positives had 47,XYY karyotype and an average percent Y allele signal above the upper threshold; any 47,XYY sample with the average percent Y allele signal below the upper limit was scored as false negative. True negatives (46,XY) had the average percent Y allele signal less than or equal to the upper limit; false positives had the average percent Y allele signal above the upper limit.Examination of the ROC curves indicated that a percent Y allele signal scoring threshold of 43% for 47,XXY and 48,XXXY syndromes and 57% for 47,XYY syndrome yielded 100% sensitivity with a 0% false positive rate. Combining the two thresholds gave a percent Y allele signal range of 43-57% for 46,XY samples. Separate analysis of the individual XYM marker data and the median of the three XYM values generated ROC curves which overlapped the curve generated with the average XYM values; thresholds of 43% and 57% allow the detection of KS and 47,XYY syndrome with 100% sensitivity and specificity using the data from either each individual marker or the median value.Detection of 48,XXYY syndromeAs noted above, the percent Y allele signals from 48,XXYY individuals (n = 45) and 46,XY males (n = 206) showed nearly complete overlap (Figure 3 and Table 1). To distinguish these karyotypes, four XA markers were amplified by PCR and the resulting products examined by Pyrosequencing. Figure F5 5 is a plot of the average percent X allele for the four XA markers graphed versus the sample ID. The average percent X allele signal differed for the samples with 48,XXYY and 46,XY karyotypes and was close to the expected values of 50% and 33.3%, respectively, based on the known chromosome ratios (Table 2). ROC analysis (Figure F6 6) performed by comparing the average percent X allele for the four XA markers with a threshold varying from 33-52% in 1% increments indicated that a threshold of 43% gave 100% detection of 48,XXYY karyotype with a 0% false positive rate.Figure 5Average percent X allele signal of four XA markers versus sample ID for male samples with 46,XY and 48,XXYY karyotypes.
Average percent X allele signal of four XA markers versus sample ID for male samples with 46,XY and 48,XXYY karyotypes. The average percent X allele signal is the average for all four markers of the ratio of signal from the X-chromosome specific allele divided by the total signal from both the X-chromosome and autosome specific alleles, expressed as a percentage.
1687-9856-2012-8-5 Figure 6Receiver operator characteristic curves for detection of 48,XXYY syndrome.
Receiver operator characteristic curves for detection of 48,XXYY syndrome. The average and median of the four XA marker data points for each sample was calculated: either the average, median or individual marker data was compared to the threshold for detecting 48,XXYY syndrome. The threshold was varied by 1% increments from 33-52% X allele signal. The sensitivity (TP/(TP + FN)) and false positive rate (FP/(FP + TN)) were calculated for each value of the appropriate threshold. True positives (TP) have a 48,XXYY karyotype and X allele signal greater than the threshold; false negatives (FN) have the same karyotype and X allele signal less than or equal to the threshold. True negatives (TN) have a 46,XY karyotype and X allele signal less than or equal to the threshold; false positives (FP) have a 46,XY karyotype and X allele signal above the threshold.